Tag Archive
Gynaecologists in Noida
Best Gynaecologists in Noida treat women's gynaecology problems related to infertility, menstruation. Most gynaecologists are obstetricians and offer pregnancy & childbirth care. Noida is one of cornerstones of the National Capital Region (NCR) in the recent times. The ever growing population of Noida has necessitated for experienced doctors, especially gynaecologists, to help treat women patients... »
Gynaecologists in Indirapuram
Gynaecologists in Indirapuram treat women's gynaecology problems including menstruation. Most Indirapuram gynaecologists are obstetricians - pregnancy & childbirth care. Indirapuram has emerged as one of the most vibrant residential area in NCR in the recent times. The evergrowing population of Indirapuram has necessitated for experienced doctors, especially gynaecologists, to help treat women patients with not... »
Gynaecologists in Delhi
Gynaecologists in Delhi help women with gynaecology issues including menstruation. Most Delhi gynaecologists are obstetricians - pregnancy & childbirth care. Gynaecology refers to the surgical specialty dealing with health of the female reproductive system that includes uterus, vagina and ovaries. Some of the common operations that Delhi gynaecologists perform include but are not limited to Curettage,... »
- Press Release (PharmiWeb)
Merck & Co. Inc. Posted on:17 Feb 10 Merck & Co., Inc. announced today that in new Phase III data, GARDASIL ® [Human Papillomavirus Quadrivalent (Types 6, 11, 16 and 18) Vaccine, Recombinant] was 77.5 percent (95 percent CI: 39.6, 93.3) efficacious against anal intraepithelial neoplasia (AIN) associated with human papillomavirus (HPV) types 6, 11, 16 and 18 in 16-to-26 year-old men who have sex ... - In Phase III Data Merck's GARDASIL® Was Efficacious Against Anal Disease Caused by HPV-6,11,16 and 18 (Business Wire via Yahoo! Finance)
WHITEHOUSE STATION, N.J.----Merck & Co., Inc. announced today that in new Phase III data, GARDASIL® [Human Papillomavirus Quadrivalent Vaccine, Recombinant ] was 77.5 percent efficacious against anal intraepithelial neoplasia associated with human papillomavirus types 6, 11, 16 and 18 in 16-to-26 year-old men who have sex with men.
Cervical Excision Procedures Causes, Symptoms, Diagnosis, Treatment, and Prognosis